According to Roche's latest financial reports the company's current EPS (TTM) is HK$130.67. In 2022 the company made an earnings per share (EPS) of HK$130.67 a decrease over its 2021 EPS that were of HK$139.43.
Year | EPS | Change |
---|---|---|
2022 | HK$130.67 | -6.29% |
2021 | HK$139.43 | -5.53% |
2020 | HK$147.60 | 16.56% |
2019 | HK$126.63 | 30.3% |
2018 | HK$97.18 | 20.22% |
2017 | HK$80.83 | -5.81% |
2016 | HK$85.82 | 4.62% |
2015 | HK$82.03 | -5.13% |
2014 | HK$86.47 | -25.05% |
2013 | HK$115.37 | 21.73% |
2012 | HK$94.77 | 3.82% |
2011 | HK$91.28 | 8.16% |
2010 | HK$84.39 | 23.72% |
2009 | HK$68.21 | -12.31% |
2008 | HK$77.78 | -0.34% |
2007 | HK$78.05 | 32.13% |
2006 | HK$59.07 | 42.56% |
2005 | HK$41.44 | -22.7% |
2004 | HK$53.60 | 132.85% |
2003 | HK$23.02 | -154.73% |
2002 | -HK$42.06 | -209.09% |
2001 | HK$38.55 | -57.25% |
2000 | HK$90.18 | 54.06% |
1999 | HK$58.53 | 31.24% |
1998 | HK$44.60 |